Horm Metab Res 2008; 40(9): 614-619
DOI: 10.1055/s-0028-1082085
Review

© Georg Thieme Verlag KG Stuttgart · New York

Modulation of Insulin Action by Advanced Glycation Endproducts: A New Player in the Field

C. G. Schalkwijk 1 , O. Brouwers 1 , C. D. A. Stehouwer 1
  • 1Department of Internal Medicine, Division of General Internal Medicine, University Hospital Maastricht, The Netherlands
Weitere Informationen

Publikationsverlauf

received 27.10.2007

accepted 21.02.2008

Publikationsdatum:
15. September 2008 (online)

Zoom Image

Abstract

Insulin resistance is characterized by an impaired responsiveness to the action of insulin at its multiple target organs. The accumulation of advanced glycation endproducts (AGEs) has been demonstrated in clinical settings of insulin resistance such as in diabetes, hypertension, and obesity. In this review we have focused on advanced glycation as a modulator of insulin resistance. Structural and functional abnormalities of the insulin molecule by glycation and methylglyoxal may contribute to the pathogenesis of insulin resistance. In addition, it is likely that AGEs interfere in the complex molecular pathways of insulin signaling and as such in insulin resistance.